|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Amarin Corp. plc, of London, said it intends to seek secondary listings on the AIM Market of the London Stock Exchange and the IEX Market of the Irish Stock Exchange. The neuroscience company, which plans to retain its primary listing on Nasdaq, is not seeking any additional capital as part of the listing process. Admission to the new exchanges is expected to occur in the middle of next month for Amarin, which reported $33 million in reserve cash on March 31.
o BioDelivery Sciences International Inc., of Morrisville, N.C., said it believes that it will be allowed to advance its new drug application for Emezine (prochlorperazine maleate) buccal tablets with two ...